लोड हो रहा है...

NK cells mediate clearance of CD8(+) T cell–resistant tumors in response to STING agonists

Several immunotherapy approaches that mobilize CD8(+) T cell responses stimulate tumor rejection, and some, such as checkpoint blockade, have been approved for several cancer indications and show impressive increases in patient survival. However, tumors may evade CD8(+) T cell recognition via loss o...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Sci Immunol
मुख्य लेखकों: Nicolai, Christopher J., Wolf, Natalie, Chang, I-Chang, Kirn, Georgia, Marcus, Assaf, Ndubaku, Chudi O., McWhirter, Sarah M., Raulet, David H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228660/
https://ncbi.nlm.nih.gov/pubmed/32198222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.aaz2738
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!